[Alkylating agents, antimetabolites, alkaloids].
Yamada
Mitsuhiro
M
Department of Central Clinical Laboratories, Osaka Red Cross Hospital.
D000470:Alkaloids / Q000008:administration & dosage* / Q000097:blood* / Q000493:pharmacokinetics / Q000633:toxicity; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000097:blood* / Q000493:pharmacokinetics / Q000633:toxicity; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage* / Q000097:blood* / Q000493:pharmacokinetics / Q000633:toxicity; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000097:blood* / Q000493:pharmacokinetics / Q000633:toxicity; D015415:Biomarkers / Q000097:blood; D002849:Chromatography, Gas; D002851:Chromatography, High Pressure Liquid; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods*; D016231:Fluorescence Polarization Immunoassay; D006801:Humans; D007124:Immunoenzyme Techniques; D012016:Reference Values; D013048:Specimen Handling
D000470:Alkaloids; D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D000972:Antineoplastic Agents, Phytogenic; D015415:Biomarkers